Xiang Z, Bugnoli M, Ponzetto A, Morgando A, Figura N, Covacci A, Petracca R, Pennatini C, Censini S, Armellini D
Immunobiological Research Institute Siena, Italy.
Eur J Clin Microbiol Infect Dis. 1993 Oct;12(10):739-45. doi: 10.1007/BF02098460.
The possibility of using a recombinant fragment of the CagA (128 kDa protein) for the diagnosis of Helicobacter pylori infection was evaluated. Following cloning of the gene coding for the CagA, a recombinant fragment of it was expressed in Escherichia coli, purified and used in Western blot and an EIA to screen sera from 82 patients with gastroduodenal disease who underwent endoscopic examination. In Western blot, good correlation was found between the serological data obtained with the recombinant antigen and those obtained using non-purified extracts of Helicobacter pylori. The EIA using the antigen showed a sensitivity of 96.2% and a specificity of 96.6% compared with Western blot. These data indicate that the recombinant protein is a reliable antigen for detection of infections with Helicobacter pylori strains that are associated with disease. The EIA assay described may be used in follow-up of the progression of the illness and the results of therapy.
评估了使用CagA(128 kDa蛋白)重组片段诊断幽门螺杆菌感染的可能性。在克隆编码CagA的基因后,其重组片段在大肠杆菌中表达、纯化,并用于蛋白质印迹法和酶免疫测定,以筛查82例接受内镜检查的胃十二指肠疾病患者的血清。在蛋白质印迹法中,发现使用重组抗原获得的血清学数据与使用幽门螺杆菌非纯化提取物获得的数据具有良好的相关性。与蛋白质印迹法相比,使用该抗原的酶免疫测定显示敏感性为96.2%,特异性为96.6%。这些数据表明,重组蛋白是检测与疾病相关的幽门螺杆菌菌株感染的可靠抗原。所述的酶免疫测定可用于疾病进展和治疗结果的随访。